Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences
Summary
The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.
Official title: Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized, Multicenter, Double-blind, Placebo-controlled Trial
Key Details
Gender
All
Age Range
35 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-04-07
Completion Date
2027-12
Last Updated
2024-08-20
Healthy Volunteers
No
Conditions
Interventions
Songling Xuemaikang Capsules
3 capsules at a time, three times a day, duration: 12 weeks
Lifestyle intervention
everyday, duration: 12 weeks
Placebo
3 capsules at a time, three times a day, duration: 12 weeks
Locations (5)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China
Suzhou Hosptial of Traditional Chinese Medicine
Suzhou, Jiangsu, China
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, China
China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital
Jining, Shandong, China
China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital
Taiyuan, Shanxi, China